Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with high morbidity if untreated. Sometimes, despite aggressive treatments, the disease remains active with cumulative organic damage. We conducted a retrospective and descriptive observational study of patients with SLE...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonilla-Abadía, Fabio, Coronel Restrepo, Nicolás, Tobón, Gabriel J., Echeverri, Andrés F., Muñoz-Buitrón, Evelyn, Castro, Andres Mauricio, Bejarano, Mercedes Andrade, Cañas, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914290/
https://www.ncbi.nlm.nih.gov/pubmed/24527208
http://dx.doi.org/10.1155/2014/731806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914290/
https://www.ncbi.nlm.nih.gov/pubmed/24527208
http://dx.doi.org/10.1155/2014/731806

Ejemplares similares